AngioDynamics raises 2026 revenue guidance to $314M while advancing Med Tech growth
Source: SeekingAlpha
2026-01-06 10:18:48 ET
More on AngioDynamics
- AngioDynamics, Inc. (ANGO) Q2 2026 Earnings Call Transcript
- AngioDynamics, Inc. 2026 Q2 - Results - Earnings Call Presentation
- AngioDynamics: Growth Remains Under The Radar
- AngioDynamics Non-GAAP EPS of $0.00 beats by $0.10, revenue of $79.43M beats by $3M
- AngioDynamics FQ2 2026 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
AngioDynamics raises 2026 revenue guidance to $314M while advancing Med Tech growth
AngioDynamics Inc.
NASDAQ: ANGO
ANGO Trading
2.67% G/L:
$10.95 Last:
82,235 Volume:
$10.75 Open:
ANGO Latest News
February 27, 2026 03:57:23 pm
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
February 23, 2026 04:30:00 pm
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
February 19, 2026 08:30:00 am
AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform
February 05, 2026 08:00:00 am
AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care
ANGO Stock Data
$455,039,941
38,744,343
2.99%
58
N/A
Medical Equipment & Supplies
Healthcare
US
Latham
